New Developments in Follicular Lymphoma: Treatment Guidance and Clinical Resources

Gain insights for the multidisciplinary team on leveraging current and emerging therapies for optimal care of patients with follicular lymphoma across multiple settings with expert-authored commentaries a text module and downloadable PowerPoint slides and clinical resource PDF. Then learn how the experts would treat your patients in the frontline and relapsed/refractory settings with an updated decision support tool.

Share

Program Content

Activities

Tazemetostat for R/R FL
My Take on the Recent Approval of Tazemetostat for Relapsed/Refractory Follicular Lymphoma
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: August 04, 2020

Expires: August 03, 2021

Updated FL Tool
An Updated Interactive Treatment Decision Support Tool for Follicular Lymphoma
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: March 18, 2021

Expires: March 17, 2022

Activities

FL Clinical Resource
Follicular Lymphoma Clinical Resource: Current Treatment Landscape and Treatment-Related Toxicity Management Guide
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: September 30, 2020

Expires: September 29, 2021

Activities

EP: FL Management Advances
ExpressPoints: Critical Advances in the Management of Follicular Lymphoma
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: October 14, 2020

Expires: October 13, 2021

Optimizing FL Management
Practical Guidance on Optimizing Management of Follicular Lymphoma
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: October 14, 2020

Expires: October 13, 2021

Activities

Follicular Lymphoma Treatment Tool
Interactive Decision Support Tool: Expert Treatment Recommendations for Patients With Newly Diagnosed or Relapsed/Refractory Follicular Lymphoma
Tool
Congratulations: You achieved a completion on 04/09/2022

Released: March 01, 2021

Expires: February 28, 2022

Faculty

cover img faculity

Emily Bucholtz, RPh

Pharmacist
Willamette Valley Cancer Institution
Eugene, Oregon

cover img faculity

John M. Burke, MD

Associate Chair
US Oncology Hematology Research Program
Rocky Mountain Cancer Centers
Aurora, Colorado

cover img faculity

Jeff DONOTUSESharman, MD

Medical Director of Hematology Research
Willamette Valley Cancer Institute
US Oncology
Eugene, Oregon

cover img faculity

Jeffrey P. DONOTUSESharman, MD

Medical Oncologist
Willamette Valley Cancer Institute and Research Center
Springfield, Oregon

cover img faculity

Nichole Fisher, RN, BSN

Clinical Research Supervisor
Willamette Valley Cancer Institute
Eugene, Oregon

cover img faculity

Ian Flinn, MD, PhD

Chief Scientific Officer
OneOncology
Nashville, Tennessee

cover img faculity

Christopher R. Flowers, MD, MS

Department Chair
Department of Lymphoma/Myeloma, Division of Cancer Medicine
University of Texas MD Anderson Cancer Center
Houston, Texas

cover img faculity

John P. Leonard, MD

Chief, Lymphoma/Myeloma Service
Division of Hematology and Oncology
Weill Medical College of Cornell University
New York Presbyterian Hospital
New York Weill Cornell Center
New York, New York

cover img faculity

Jeffrey P. Sharman, MD

Medical Director of Hematology Research
Sarah Cannon at Willamette Valley Cancer Institute
Eugene, Oregon

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Bayer Healthcare Pharma

Celgene

Epizyme, Inc.